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Abstract
Pancreaticoduodenectomy (PD), once carried high morbidity and mortality, is now a routine operation performed for
lesions arising from the pancreatico-duodenal complex. This study reviews the outcome of 101 pancreaticoduodenectomies
performed after formalization of HepatoPancreatoBiliary (HPB) unit in the Department of Surgery.
A prospective database comprising of patients who underwent PD was set up in 1999. Retrospective data for patients
operated between 1996 and 1999 was included. One hundred and one cases accrued over 10 years from 1996 to 2006 were
analysed using SPSS (Version 12.0).
The mean age of our cohort of patients was 61912 years with male to female ratio of 2:1. The commonest clinical
presentations were obstructive jaundice (64%) and abdominal pain (47%). Majority had malignant lesions (86%) with
invasive adenocarcinoma of the head of pancreas being the predominant histopathology (41%). Median operative time was
315 (180945) minutes. Two-third of our patients had pancreaticojejunostomy (PJ) while the rest had pancreaticogas-
trostomy (PG). There were five patients with pancreatico-enteric anastomotic leak (5%), three of whom (3%) were from PJ
anastomosis. Overall, in-hospital and 30-day mortality were both 3%. The median post-operative length of stay (LOS) was
15 days. Using logistic regressions, the post-operative morbidity predicts LOS following operation (pB0.005). The strategy
in improving the morbidity and mortality rates of pancreaticoduodenectomies lies in the subspecialization of surgical
services with regionalization of such complex surgeries to high volume centers. The key success lies in the dedication of
staffs who continues to refine the clinical care pathway and standardize management protocol.
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Introduction
Since the first successful removal of a periampullary
carcinoma with a sleeve of duodenum by William
Halsted in 1898 [1], many developments have taken
place with significant improvement in outcome of
pancreaticoduodenal surgery. Pancreaticoduodenect-
omy (PD) was subsequently popularized by Dr Allen
O. Whipple after his success in the initial three cases
in 1935. He published the operation in a landmark
paper and this is now commonly known as ‘‘Whipple’s
operation’’ [2].
Previously, this surgery was criticized by many as it
carried high rates of morbidity and mortality [3].
However, in recent years, the morbidity and mortality
associated with PD have dropped significantly due to
the development of subspecialization, regionalization
of this complex operation and creation of high volume
centers. Advancement in the operative techniques,
improvement in peri-operative care and standardiza-
tion of post-operative care using clinical care pathway
have also contributed significantly to the improved
outcome of this operation.
In our institution, we restructured and reorganized
the Department of General Surgery into subspeciality-
based surgical practice in 1996. Hepatopancreatobili-
ary (HPB) Surgery Unit was formalized and HPB
surgeons and nurses were recruited. In the last decade,
pancreaticoduodenectomy was performed by our HPB
and upper gastrointestinal tract (UGIT) surgeons.
This study analyses our institution’s outcome with
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the 101 pancreaticoduodenectomies performed over
the last 10 years.
Methods
A prospective database comprising of patients who
underwent PD was set up in our institution in 1999.
Through our hospital operation record book, we
included retrospective data of patients operated be-
tween 1996 and 1999. From 1996 to 2006, a total of
101 pancreaticoduodenectomies were performed.
The data was analysed using SPSS (Version 12.0)
and Stata version 9.2 (Stata Corp, Texas, USA). We
analysed the morbidity, mortality and length of stay
(LOS) after surgery. The linear regression model was
used to examine factors associated with LOS. We
analyzed LOS on the natural logarithmic scale, as we
found the residuals from the model to be not normally
distributed. Logistic regression was used to identify
predictors for morbidity and mortality. The data was
also divided into two periods, from 1999 to 2001 and
from 2002 to 2006 for comparison. Year 2002 was
selected as the cut-off as it coincided with the year
when HPB unit started implementing standardized
management protocol in our institution.
Cases that are indicated for PD are discussed at our
weekly multi-disciplinary Pancreato-Biliary Manage-
ment Conference. Cases are deemed suitable for
resection when there is no evidence of liver or
peritoneal metastases, no gross involvement of major
blood vessels. We would consider trial of resection of
portal or superior mesenteric vein if pre-operative
assessment showed close abutment of tumor to these
veins and venous reconstruction was possible. Prior to
operation, patients with significant cardiac and re-
spiratory conditions are assessed by cardiologists and
respiratory physicians respectively. All patients would
then undergo pre-operative chest physiotherapy and
incentive spirometry to minimize post-operative re-
spiratory morbidity. Smokers are advised to cease
smoking two weeks prior to the operation for the same
reason mentioned above.
Prior to 2006, only classical Whipple’s operation
was performed in our institution. Pylorus-preserving
pancreaticoduodenectomy (PPPD) was added to our
operative repertoire in early 2006. Our classical
Whipple’s operation is defined as resection of distal
third of stomach with transection of common hepatic
duct just proximal to the junction with cystic duct.
Lymph node clearance is confined to the hepatoduo-
denal ligament and retropancreatic areas up to super-
ior mesenteric vessels [4,5]. The posterior pancreatic
resection margin is at the plane posterior to portal vein
and lateral to superior mesenteric vessels. Jejunum is
transected at the first jejunal mesenteric branch. The
choice for the type of pancreatico-enteric anastomosis
is based on surgeon’s preference. End-to-side hepati-
cojejunostomy, about 10 cm distal to pancreaticojeju-
nostomy, constructed using interrupted 4/0 or 5/0
Polydiaxanone (PDS† Ethicon, Inc, Johnson & John-
son) suture is our usual practice [6,7]. Gastrojejunost-
omy is performed with an omega loop in end-to-side
fashion. For PPPD, the distal stomach and pylorus are
preserved and duodenojejunostomy is reconstructed
with an antecolic omega jejunal loop, 70 cm from the
hepaticojejunostomy.
A standard post-operative care pathway is used for
post-operative management in the wards. Patients are
kept nil by mouth with nasogastric tube to passive
drainage and aspiration at four hourly intervals. A
single dose of 200 mcg of subcutaneous sandostatin is
administered during pancreatic transection and this is
continued for one week post-operatively. The dose is
dependent on the consistency of the pancreatic tissue
assessed during operation. If the pancreas is soft or
pancreatic duct is B3 mm, 200 mcg at eight hourly
dosing interval is administered, otherwise 100 mcg
eight hourly is given [6]. Patients are allowed non-
milk feeds if nasogastric output is B100 ml on first
post-operation day [POD] and nasogastric tube is
removed on second POD if the output remains B100
ml. Feeding is graduated as tolerated. In general, by
third to fourth POD, patients will be taking full diet.
Drain fluid and serum amylase are performed on
first, third and fifth POD. The drain fluids from
surgical tubes placed in the subhepatic space and left
infracolic compartment are assayed. We defined
pancreatico-enteric anastomotic leakage when the
drain fluid amylase level is more than 3X serum
amylase and drainage from pancreatic bed is more
than 100 ml per day from the fifth post-operative day
[816]. All complications were documented clearly
and graded according to the classification proposed by
Clavien et al. in 1992. [1720].
All histology specimens were examined and re-
ported by our in-house pathologists. When the origin
of the cancer at the ampullary region could not be
convincingly demonstrated, peri-ampullary carci-
noma is reported. Our post-discharge follow-up
schedule comprises of three monthly clinic reviews
in the first two years, half-yearly review in the
subsequent three years and yearly follow-up if patient
is disease free after five years from the surgery.
Routine CT imaging is not mandatory unless patient
is symptomatic or has elevated serum tumor marker
level on follow-up.
Results
Demography
The mean age of our cohort of 101 patients was 619
12 years. Sixty-two percent were male. Seventy-eight
percent of them were Chinese; Malay and Indian
comprised 6% and 9%, respectively. Two-third of
them had one or more comorbidities. The two most
common comorbidities were hypertension (29%) and
diabetes mellitus (18%). All the patients had ASA
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grade 53, slightly more than half (53%) of the
patients were graded ASA 2.
Presentation and pre-operative procedure
The commonest clinical presentations were obstruc-
tive jaundice (64%) and abdominal pain (47%) for a
variety of diagnoses (Figure 1). Majority of patients
had malignancy arising from the pancreaticoduodenal
complex (83%).
About one-third of our patients underwent pre-
operative endobiliary stenting (29%) for either in-
fective or non-infective obstructive biliopathy. This
represented half of our patients who presented with
obstructive jaundice.
Operative data
All pancreaticoduodenectomies were performed by
either HPB or UGIT surgeon in our institution. All
were elective cases except for one patient who under-
went emergency PD for a traumatic pancreatic
transection following motor-vehicle accident. Ten
patients (10%) underwent pylorus-preserving pan-
creaticoduodenectomy (PPPD).
The median length of operation was 315 (180945)
minutes. The outlier of the operation duration was a
man with chronic pancreatitis who developed carci-
noma of the head of pancreas. Because of his two
previous upper abdominal operaions and chronic
pancreatitis, 34 hours were spent on adhesiolysis
prior to pancreaticoduodenectomy. Median estimated
intra-operative blood loss was 500 (1506400) ml.
The median blood transfusion was 1.6 (07.0) units.
The same patient mentioned above had 6400 ml of
intra-operative blood loss due to prolonged and
extensive dissection. Two-third of our patients
(69%) had pancreaticojejunostomy (PJ) while the
rest (31%) had pancreaticogastrostomy (PG). Prior
to 2003, subcutaneous sandostatin was administered
selectively and this practice was embedded as part of
our standardized peri-operative care protocol only
from 2003 onwards.
Pathology
Malignancies arising from the head of pancreas (32%)
and ampulla of Vater (32%) were the two commonest
pathology (Table I). Seventy-two percent of them
were moderately differentiated in histological grade.
The median tumor size for malignant lesions was
27 (5160) mm.
Post-operative outcome
Most of the patients were monitored in the surgical
high dependency (SHD) ward for a median of
3 (110) days. The median post-operative LOS was
11 (490) days. One-third (37%) of our patients had
peri-operative morbidity. The majority of these are
complications arising from wound infections, intra-
abdominal complications, intestinal complications,
bleeding, respiratory complications and anastomotic
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Figure 1. Clinical presentation of patients prior to surgery.
Table I. Pathological diagnoses of patients who underwent PD in
our institution.
Site of lesion No. (%)
Head of pancreas
Benign Serous cystadenoma 2
Mucinous cystadenoma 1
Cavernous lymphangioma 1
Inflammatory Chronic pancreatitis 4
Inflammatory pseudocyst 1
Malignant IPMT 4
Neuroendocrine tumour 2
Invasive adenocarcinoma 32 46.6
Ampulla of Vater
Benign Dysplastic adenoma 2
Malignant Invasive adenocarcinoma 32 33.7
Periampullary
Malignant Invasive adenocarcinoma 6 5.9
Duodenal
Benign AVM 1
Malignant Invasive adenocarcinoma 5 5.9
Distal CBD
Malignant Cholangiocarcinoma 3 3.0
Others 5 5.0
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leak (Table II). Most of these morbidities were Grade
2 complications (24%). There were five pancreatico-
enteric anastomotic leaks (5%) of which three (3%)
were from PJ anastomosis (Figure 2). There was one
bile leak from hepaticojejunostomy dehiscence.
Eight patients (8%) in our series required un-
planned re-operations within two weeks after PD
due to various complications (Table III). Five re-
operations were performed to address complications
arising from anastomotic leak.
Overall, in-hospital and 30-day mortality were both
3%. There were two mortalities, one from acute renal
failure following postoperative sepsis, while another
from acute myocardial infarction in the first week of
operation. The third patient passed away from pan-
creaticoduodenal artery haemorrhage on the fifth
post-operative day. The diagnosis was made promptly
but patient adamantly declined surgical intervention
after failed attempts at angiographic dearterialization.
Predictors of outcome
Using logistic regression, age (p0.05) and gender
(p0.05) did not influence post-operative LOS
(Table IV). However, the presence of any morbidity
significantly prolongs the post-operative LOS
(pB0.05). As the post-operative LOS was not nor-
mally distributed, log transformation was performed
and subsequent linear regression showed that Grade 2
(pB0.001) and 3 (p0.003) complications were
significantly associated with longer post-operative
LOS (Table V). When analyzing anastomotic leak as
Table II. Table of comparison for morbidities after PD surgery.
n101 cases %
Wound complication
Wound infection 4 4
Burst abdomen 1 1
Intra-abdominal complication
Intra-abd sepsis 5 5
Peripancreatic collection 1 1
Other intra-abd collection 3 3
Anastomotic leak
PJ leak 3 3
PG leak 2 2
HJ leak 1 1
Intestinal complication
Ileus 4 4
Prolonged biliary to bowel transit 1 1
Delayed gastric emptying 5 5
IO  efferent loop partial obstruction 1 1
Gastric outlet obstruction 1 1
Dumping syndrome 1 1
Bleeding complication
BGIT 3 3
Intra-abd bleeding 3 3
Chest complication
Pneumonia 4 4
Pleural effusion 3 3
Pulmonary oedema 1 1
Prolonged ventilation 2 2
Atelectasis 2 2
Other complication
Enterocutaneous fistula 1 1
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Figure 2. Types of pancreaticoenteric anastomosis and anastomotic
leak rate.
Table IV. Predictors of outcome for pancreaticoduodenectomies.
Variables P-value
Post-op LOS vs.
Age 0.59
Gender 0.33
Anastomotic Leak vs.
Somatostatin administration 0.40
PJ vs. PG 0.90
SICU LOS 0.56
SHD LOS 0.38
Post-op LOS 0.20
Pre-op endobiliary stenting vs.
Infective complication 0.73
Note: P-value B0.05 as statistically significant. PJ, pancreaticoje-
junostomy; PG, pancreaticogastrostomy; SICU, Surgical Intensive
Care Unit; SHD, Surgical High Dependency Unit; LOS, length of
stay.
Table III. Reasons for repeat exploratory laparotomy in patients
after pancreaticoduodenectomy.
Operation and findings
Anastomotic leak
related
1. PG leak with laparotomy and refashioning
of PG and CJ/repair of burst abdomen
2. Exploratory laparotomy and evacuation of
hemoperitoneum
3. Take down of PJ, drainage of collection,
revision of HJ
4. Take down of PG and partial gastrectomy
5. DJ stenting across HJ leak and T-tube
Not related to leak 6. Gastric outlet obstruction with laparotomy
and adhesiolysis done
7. Exploratory laparotomy for delayed gastric
emptying
8. Resection of tumor margin due to tumor
involvement
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an independent variable, it did not significantly
increase the LOS in Surgical Intensive Care Unit
(SICU), SHD or post-op LOS (Table IV). This could
be due to the small sample size in our cohort of
patients.
In our series, the use of pre-operative endobiliary
stent in obstructed biliary track was also not found to
increase post-operative infective complications (p
0.73). However, low post-operative hemoglobin level
(p0.04) and elevated pre-operative (p0.03) bilir-
ubin level at presentation significantly correlated with
higher morbidity. Although half of the patients had
somatostatin analogue administration peri-opera-
tively, this had not been shown to decrease the rate
of anastomotic leak (p0.40) (Table IV). We also did
not find a significant difference in anastomotic leak
rate between PJ and PG anastomosis techniques
(p0.90). Again, the small sample size is a plausible
explanation to this observation.
Comparing outcomes of two periods
To analyze the outcome after standardized peri-
operative PD management protocol was implemented
in 2002, we divided the data into two periods, first five
years (19962001) and second five years (2002
2006). While there were more PJ (n37) than PG
(n7) performed after year 2002, there was no
difference in terms of age, gender, race, ASA grade,
operative time and intra-operative blood loss between
the two periods.
Further analysis of this data using student’s t-test
showed that the LOS in terms of total LOS and post-
operation LOS were significantly shorter for PD done
after year 2002 (Table VI). Comparing the mortality
and morbidity between these two periods, the mor-
tality has dropped from 5 to 0% while overall
morbidity dropped from 42 to 25%. The leak rate
has also decreased from 7 to 2%. Using Fisher’s exact
test, these differences did not reached statistical
significance.
Discussion
Operative outcomes of pancreaticoduodenectomy
(PD) have been widely published in the western
countries in the past decade but literatures from Asian
centers are limited. There is paucity of outcome data
for Whipple’s operation in Singapore. In this study,
we share our one decade of experience in pancreati-
coduodenectomy and review the outcome of PD in a
tertiary teaching hospital.
In our institution, this operation was initially
performed by general surgeons. However, as we
progress toward subspecialization, this operation is
now commonly performed by specialized trained
HPB surgical team since 1996 in our institution.
This trend is in tandem with the global phenomenon
of subspecialty-based surgical practice and regionali-
zation of major and complex operations to high-
volume centers [21]. This has resulted in significant
improvement in mortality and morbidity rates. Singa-
pore is a small island country with an average
population of about three million people. With the
influx of immigrants after the millennium, the popu-
lation now is about four million people. Our hospital
has a healthcare catchment area of 11.5 million of
people, serving the Northern and North-eastern part
of the country.
Our overall in-hospital and 30-day mortality rate of
3% is comparable to other specialized centers in this
region. Poon et al. from Hong Kong reported a hospital
mortality rate of 2.9% in 140 patients over a 12-year-
period [22]. Simliarly, these numbers were also con-
sistent with the mortality rate quoted from various
high-volume centers around the world [2332].
Birkmeyer et al. noticed that there was a trend toward
regionalizing pancreaticoduodenectomy to high-vo-
lume centers in the USA due to better results and
lower in-hospital mortality rate. They divided the
hospital’s average annual volume of pancreatocoduo-
denectomies into four categories: very low (B1/year),
low (B12/year), medium (25/year) and high
(5/year). They observed that in-hospital mortality
rates at low and very low-volume hospitals were three
to fourfold higher than at high-volume hospitals [31].
This was supported by Gordon et al who found that
centers with high volume (20 cases per year) had
lower mortality rate for PD at 2.2% while low-volume
centre (15 cases per year) had higher mortality rate at
19.1% [32]. By Birkmeyer’s definition, our institution
falls into the high-volume center (medium volume by
Gordon’s definition), and the mortality rate correlates
well with the operative volume.
Table V. Linear regression of post-operative LOS vs. grade of
complications (GOC).
Log post-op LOS P-value Median p25 p75
GOC Grade 0 vs 9.5 8 12
GOC 1 0.056 17 11 31
GOC 2 B0.001 18 11.5 27.5
GOC 3 0.003 17 9 41
GOC 4 0.82 10 6.5 22
Note: p25, 25th percentile; p75, 75th percentile. GOC, Grade of
complications based on Clavien et al. [17]. P-values obtained from
linear regression model with LOS analyzed on the logarithmic scale.
Table VI. Comparison of LOS before and after year 2001.
Median
Variables (Days) Before 2001 After 2001 P-value
LOS in SICU 0 0 0.27
LOS in HD 3 3 0.84
Total LOS 20 10 B0.001
Post-op LOS 13.5 9 0.001
(pB0.05 as statistically significant)
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Many high-volume centers reported overall mor-
bidity rate of PD of about 4150% [22,3341]. In
our series, 35% of our patients had one or more
morbidities and this was again comparable to that
reported by Poon et al. from Hong Kong (38.6%)
[22]. Majority of our morbidity was grade 2 com-
plication. However, implementation of a standar-
dized management protocol and care pathway has
been shown to significantly decrease the risk of
complications. Many centers have shown that proto-
colized management by an experienced team com-
prising of surgeons, nurses and anesthesia medical
staffs can effectively improve clinical outcome. In
specialized centers, post-operative and overall LOS
decreased with increased experience of the specia-
lized team. Operation performed by a dedicated
team helps to minimize leak rate and shorten LOS.
This is due to familiarity with the operation and
better surgical techniques.
As mentioned earlier, the choice of pancreatico-
enteric anastomosis, i.e. PJ or PG, is entirely based on
surgeon preference in our center. Randomized con-
trolled trials revealed no significant difference between
PJ and PG regarding overall postoperative complica-
tions, pancreatic fistula, intra-abdominal collection or
mortality [4244]. Although non-randomized obser-
vational clinical studies showed significant results in
favor of PG in terms of reduction in pancreatic fistula
and mortality rate [4557], meta-analysis concluded
no significant difference between the two techniques
[58,59]. In our series, we did not observe any differ-
ence in outcome between PJ and PG.
The other strength of a matured surgical team is that,
as the team gathers more experience and momentum in
performing PD, it allows them to explore and introduce
improved modifications to the techniques of Whipple’s
operation. Over the years, there have been many
creative modifications to performing PD. One such
technique that has gained popularity as well as con-
troversy is the pylorus-preserving pancreaticoduode-
nectomy (PPPD). Our institution started to perform
this operation in early 2006, nine years after our
subspecialized hepatobiliary surgery service was for-
malised. We have also developed new modifications to
the technique of pancreatic anastomosis as we continue
to explore this operation. Our current preferred PJ
technique is duct-to-mucosa in two layers.
Our 10 years of audited data has helped us to
reshape the patient care protocol and refine the
surgical techniques required in performing PD. As
we strive to improve the outcome of our patients
undergoing PD, we periodically review our database
to explore further opportunity to improve our surgical
techniques and care protocol. With the management
protocol that was implemented, the outcome has
improved remarkably.
Conclusion
The strategy in improving the morbidity and mortality
rates of pancreaticoduodenectomies lies in the sub-
specialisation of surgical services with regionalization
of such complex surgeries to high-volume centers.
The key success lies in the dedication of staffs who
continue to refine the clinical care pathway and
standardize management protocol. Given such safety
profile, it is therefore justified to extend the indication
of PD to benign conditions and presumed malignant
pathology arising from pancreaticoduodenal complex.
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